The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2R,4R)-1-benzyl-4-(4-(3-(hydroxycarbamoyl)phenyl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxylic acid ID: ALA3793416
Chembl Id: CHEMBL3793416
PubChem CID: 137175009
Max Phase: Preclinical
Molecular Formula: C21H21N5O4
Molecular Weight: 407.43
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NO)c1cccc(-c2cn([C@@H]3C[C@H](C(=O)O)N(Cc4ccccc4)C3)nn2)c1
Standard InChI: InChI=1S/C21H21N5O4/c27-20(23-30)16-8-4-7-15(9-16)18-13-26(24-22-18)17-10-19(21(28)29)25(12-17)11-14-5-2-1-3-6-14/h1-9,13,17,19,30H,10-12H2,(H,23,27)(H,28,29)/t17-,19-/m1/s1
Standard InChI Key: RKIIWZWOQGYILB-IEBWSBKVSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 407.43Molecular Weight (Monoisotopic): 407.1594AlogP: 1.96#Rotatable Bonds: 6Polar Surface Area: 120.58Molecular Species: ZWITTERIONHBA: 7HBD: 3#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 1.37CX Basic pKa: 9.60CX LogP: -0.45CX LogD: -0.46Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.42Np Likeness Score: -1.28
References 1. Tian Y, Jin J, Wang C, Lv W, Li X, Che X, Gong Y, Li Y, Li Q, Hou J, Wang PG, Shen J.. (2016) A sub-milligram-synthesis protocol for in vitro screening of HDAC11 inhibitors., 26 (10): [PMID:27055940 ] [10.1016/j.bmcl.2016.03.116 ]